Otitis externa historical perspective

Revision as of 23:29, 29 July 2020 by WikiBot (talk | contribs) (Bot: Removing from Primary care)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Otitis externa Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Otitis Externa from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Otitis externa historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Otitis externa historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onOtitis externa historical perspective

CDC on Otitis externa historical perspective

externa historical perspective in the news

on Otitis externa historical perspective

Directions to Hospitals Treating Otitis externa

Risk calculators and risk factors for Otitis externa historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.; Tarek Nafee, M.D. [2]

Overview

Otitis externa was first identified in 1873 by Adam Politzer, classified and recorded as one of the otological pathologies codified in his otology clinic in Austria. Burow's solution, a therapeutic application of aqueous aluminium acetate, was invented by Karl August Burow in the mid-19th century. Antibiotic therapy for chronic otitis externa treatment emerged with the invention of mass production of penicillin in 1940 by Alexander Fleming, Howard Florey, and Ernst Chain. Corticosteroid therapy to relieve pain and itching from otitis externa emerged with the discovery of the glucocorticoid dexamethasone in 1957. The current therapy of "ear drops," or topical application of antibiotics, began to be administered to otitis externa patients in 1987 after the discovery of ciprofloxacin, a fluoroquinolone-class antibiotic.

Historical Perspective

  • German physicians Hermann Schwartze, Anton von Troltsch, and Adam Politzer advanced the discourse of clinicial study of otitis externa by publishing the first journal dedicated to ear pathology and treatment in 1865.[1]
  • Adam Politzer founded the first otology clinic in 1873 in Austria, beginning the codification and standardization of ear disease treatment, such as otitis externa.
  • Burow's solution, a therapeutic application of aqueous aluminium acetate, was invented by Karl August Burow in the mid-19th century that is still used presently as a topical remedy for otitis externa.[2]
  • Antibiotic therapy for chronic otitis externa treatment emerged with the invention of mass production of penicillin in 1940 by Alexander Fleming, Howard Florey, and Ernst Chain.[3]
    • This was the first instance of the modern use of antibiotic therapy for otitis externa treatment.
  • Corticosteroid therapy to relieve pain and itching from otitis externa emerged with the discovery of the glucocorticoid dexamethasone in 1957.[4]
  • The "tektite solution" therapy of 15% tannic acid, 15% acetic acid, and 50% isopropanol or ethanol, emerged in 1969 in response to high incidence of otitis externa in biologists involved in the Tektite I diving mission.[5]
  • The current therapy of "ear drops," or topical application of antibiotics, began to be administered to otitis externa patients in 1987 after the discovery of Ciprofloxacin, a fluoroquinolone-class antibiotic.[6][7]

References

  1. Bento RF, Fonseca AC (2013). "A brief history of mastoidectomy". Int Arch Otorhinolaryngol. 17 (2): 168–78. doi:10.7162/S1809-97772013000200009. PMC 4423283. PMID 25992009.
  2. REES CW (1949). "Otitis externa". Calif Med. 70 (4): 288–91. PMC 1643794. PMID 18116233.
  3. Diamant H, Hultcrantz M (1996). "[Glimpses from the history of otitis media]". Nord Medicinhist Arsb (in Swedish): 189–95. PMID 11624973.
  4. Rankovic, Zoran; Bingham, Matilda; Nestler, Eric J; Hargreaves, Richard (2012). doi:10.1039/9781849734943. ISSN 2041-3211. Missing or empty |title= (help)
  5. Shilling, Charles W. (Charles Wesley); Werts, Margaret F, (joint author.) (1971), An annotated bibliography on diving and submarine medicine, Gordon and Breach, ISBN 978-0-677-03910-7
  6. "Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations".
  7. Mösges R, Nematian-Samani M, Eichel A (2011). "Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution". Ther Clin Risk Manag. 7: 325–36. doi:10.2147/TCRM.S6769. PMC 3150478. PMID 21845055.

Template:WH Template:WS